We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
-3.36%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$23.6B
AUM Growth
-$1.2B
(-4.8%)
Cap. Flow
-$152M
Cap. Flow
% of AUM
-0.64%
Top 10 Holdings %
Top 10 Hldgs %
59.63%
Holding
1,742
New
84
Increased
209
Reduced
452
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$117M |
| 2 |
Entegris
ENTG
|
+$107M |
| 3 |
Teleflex
TFX
|
+$26.6M |
| 4 |
Nike
NKE
|
+$25.8M |
| 5 |
S&P Global
SPGI
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.9M |
| 2 |
Meta Platforms (Facebook)
META
|
+$53.8M |
| 3 |
IAA
IAA, Inc. Common Stock
IAA
|
+$39.5M |
| 4 |
Amazon
AMZN
|
+$37.6M |
| 5 |
UnitedHealth
UNH
|
+$30M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.69% |
| 2 | Technology | 15.09% |
| 3 | Healthcare | 11.64% |
| 4 | Consumer Discretionary | 8.73% |
| 5 | Communication Services | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CME Group
CME
$91.9B
| $27.5M | 0.12% |
155,465
-5,313
| -3% | -$1.05M |
|
77
Citigroup
C
$221B
| $27.5M | 0.12% |
659,952
-16,014
| -2% | -$791K |
|
78
Union Pacific
UNP
$181B
| $26.7M | 0.11% |
137,132
+831
| +0.6% | +$184K |
|
79
Nutrien
NTR
$32.9B
| $26.4M | 0.11% |
319,311
-802
| -0.3% | -$69K |
|
80
American Water Works
AWK
$26.2B
| $25.4M | 0.11% |
195,299
-552
| -0.3% | -$83.1K |
|
|
LSXMK
81
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $24.9M | 0.11% |
897,067
-354,848
| -28% | -$11M |
|
82
Brookfield Renewable
BEP
$10B
| $24.3M | 0.1% |
777,772
-210
| -0% | -$7.76K |
|
83
Snap-on
SNA
$20.5B
| $24.3M | 0.1% |
120,547
-3,630
| -3% | -$783K |
|
84
Hilton Worldwide
HLT
$72.9B
| $23.8M | 0.1% |
197,212
-23
| -0% | -$2.91K |
|
|
ATVI
85
DELISTED
Activision Blizzard
ATVI
| $23.5M | 0.1% |
316,677
-6,691
| -2% | -$524K |
|
86
Boston Scientific
BSX
$64.8B
| $23.4M | 0.1% |
603,317
+4,150
| +0.7% | +$166K |
|
87
Wells Fargo
WFC
$261B
| $23M | 0.1% |
571,061
-926
| -0.2% | -$39.8K |
|
88
BioCryst Pharmaceuticals
BCRX
$2.38B
| $22.7M | 0.1% |
1,805,072
| – | – |
|
89
PepsiCo
PEP
$184B
| $22.7M | 0.1% |
138,980
-2,455
| -2% | -$423K |
|
|
90
Teleflex
TFX
$5.81B
| $22.6M | 0.1% |
111,945
+111,400
| +20,440% | +$26.6M |
|
91
Graco
GGG
$12.9B
| $22.2M | 0.09% |
405,728
-8,250
| -2% | -$529K |
|
92
Diageo
DEO
$45.7B
| $21.8M | 0.09% |
136,020
-210
| -0.2% | -$37.6K |
|
93
Vanguard High Dividend Yield ETF
VYM
$80.6B
| $20.7M | 0.09% |
218,377
+1,331
| +0.6% | +$138K |
|
94
Merck
MRK
$322B
| $20.6M | 0.09% |
238,743
-7,911
| -3% | -$706K |
|
95
ExxonMobil
XOM
$650B
| $20M | 0.08% |
229,544
-1,268
| -0.5% | -$116K |
|
96
TriMas Corp
TRS
$1.44B
| $19.7M | 0.08% |
786,749
-8,195
| -1% | -$226K |
|
97
IBM
IBM
$194B
| $19.7M | 0.08% |
165,954
+2,367
| +1% | +$311K |
|
98
Abbott
ABT
$175B
| $19.5M | 0.08% |
201,431
+14,233
| +8% | +$1.52M |
|
99
Regenxbio
RGNX
$656M
| $18.7M | 0.08% |
705,730
| – | – |
|
|
IAA
100
DELISTED
IAA, Inc. Common Stock
IAA
| $17.7M | 0.08% |
556,091
-1,112,691
| -67% | -$39.5M |
|
Similar funds
SAM
First Manhattan's Q3 2022 Portfolio in Review
As of Q3 2022, First Manhattan held 1,742 positions worth $23.6B, down 4.8% from $24.8B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
First Manhattan's Q3 2022 filing shows 84 new, 209 increased, 452 reduced and 104 closed positions. Its largest new stake was Element Solutions: 151,800 shares worth $2.47M. The largest sale was Apple, an estimated $59.9M.
By sector, the portfolio is most concentrated in Financials at 44% of assets, up from 43% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2022 buy was Element Solutions: 151,800 shares worth $2.47M.
- First Manhattan added most to Linde in Q3 2022, an estimated $117M increase.
- First Manhattan's biggest Q3 2022 reduction was Apple, cutting an estimated $59.9M.
- First Manhattan fully exited Blueprint Medicines in Q3 2022, selling an estimated $29.7M.
- First Manhattan's ten largest holdings make up 60% of its $23.6B portfolio in Q3 2022.
- First Manhattan opened 84 new positions and closed 104 in Q3 2022.
- First Manhattan's portfolio value fell 4.8% quarter-over-quarter to $23.6B.
Based on First Manhattan's 13F filing for Q3 2022, filed 14 Nov 2022.